AMH Equity Ltd purchased a new stake in Hyperfine, Inc. (NASDAQ:HYPR – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 125,084 shares of the company’s stock, valued at approximately $90,000. AMH Equity Ltd owned approximately 0.16% of Hyperfine as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in the company. Virtu Financial LLC bought a new stake in shares of Hyperfine in the 4th quarter valued at approximately $25,000. Wealth Enhancement Advisory Services LLC lifted its holdings in Hyperfine by 64.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock worth $72,000 after purchasing an additional 32,093 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in Hyperfine by 32.9% in the 4th quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock worth $187,000 after purchasing an additional 52,500 shares during the last quarter. Institutional investors own 15.03% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on HYPR shares. Wells Fargo & Company reduced their target price on Hyperfine from $1.29 to $0.68 and set an “equal weight” rating for the company in a report on Wednesday, May 14th. B. Riley restated a “buy” rating on shares of Hyperfine in a report on Tuesday, June 3rd. Finally, Lake Street Capital started coverage on Hyperfine in a report on Monday, March 24th. They issued a “buy” rating and a $1.50 target price for the company.
Hyperfine Stock Down 10.7%
Shares of HYPR stock opened at $0.92 on Friday. Hyperfine, Inc. has a 12 month low of $0.53 and a 12 month high of $1.90. The firm has a market cap of $71.61 million, a PE ratio of -1.70 and a beta of 1.01. The stock has a 50 day moving average of $0.72 and a 200-day moving average of $0.85.
Hyperfine (NASDAQ:HYPR – Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.12) EPS for the quarter, hitting analysts’ consensus estimates of ($0.12). Hyperfine had a negative return on equity of 74.19% and a negative net margin of 343.42%. The company had revenue of $2.14 million during the quarter, compared to analyst estimates of $2.82 million. As a group, equities analysts predict that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.
About Hyperfine
Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.
Recommended Stories
- Five stocks we like better than Hyperfine
- Expert Stock Trading Psychology Tips
- MarketBeat Week in Review – 07/14 – 07/18
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Why Pure Storage Is a Core Investment for the AI Era
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
Want to see what other hedge funds are holding HYPR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hyperfine, Inc. (NASDAQ:HYPR – Free Report).
Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.